Management of chronic lymphocytic leukemia (CLL) in the era of B‐cell receptor signal transduction inhibitors

E-ISSN： 1096-8652|90|7|657-664

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.7, 2015-07, pp. : 657-664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HLA-G Expression as a Prognostic Indicator in B-Cell Chronic Lymphocytic Leukemia

Acta Haematologica, Vol. 132, Iss. 1, 2014-02 ,pp. : 53-58

Karger

Access to resources Recommend Favorite

Significance of Chromosomal Aberrations in CLL. Concerning Jarošová M, et al.: Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia. Onkologie 2001;24:60–65.

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 176-176

Karger

Access to resources Recommend Favorite

Contribution of Comparative Genomic Hybridization and Fluorescence in situ Hybridization to the Detection of Chromosomal Abnormalities in B-Cell Chronic Lymphocytic Leukemia

Oncology Research and Treatment, Vol. 24, Iss. 1, 2001-03 ,pp. : 60-65

Karger

Access to resources Recommend Favorite

Immunoglobulin V_H Genes and CD38 Expression Analysis in B-Cell Chronic Lymphocytic Leukemia

Acta Haematologica, Vol. 116, Iss. 1, 2006-07 ,pp. : 72-74

Karger

Access to resources Recommend Favorite

Incidence of chronic lymphocytic leukemia and high‐count monoclonal B‐cell lymphocytosis using the 2008 guidelines

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 2000-2005

John Wiley & Sons Inc

Access to resources Recommend Favorite